63 related articles for article (PubMed ID: 9010346)
1. A differential screen for ligand-regulated genes: identification of HoxA10 as a target of vitamin D3 induction in myeloid leukemic cells.
Rots NY; Liu M; Anderson EC; Freedman LP
Mol Cell Biol; 1998 Apr; 18(4):1911-8. PubMed ID: 9528762
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D
Johnson JR; Martini RN; Yuan YC; Woods-Burnham L; Walker M; Ortiz-Hernandez GL; Kobeissy F; Galloway D; Gaddy A; Oguejiofor C; Allen B; Lewis D; Davis MB; Kimbro KS; Yates CC; Murphy AB; Kittles RA
Biology (Basel); 2024 May; 13(5):. PubMed ID: 38785827
[TBL] [Abstract][Full Text] [Related]
3. Genomic and non-genomic action of vitamin D on ion channels - Targeting mitochondria.
Olszewska AM; Zmijewski MA
Mitochondrion; 2024 Apr; 77():101891. PubMed ID: 38692383
[TBL] [Abstract][Full Text] [Related]
4. Increased Epoxyeicosatrienoic Acids and Hydroxyeicosatetraenoic Acids After Treatment of Iodide Intake Adjustment and 1,25-Dihydroxy-Vitamin D
Liu Q; Zhang Y; Zhao H; Yao X
Front Physiol; 2021; 12():669652. PubMed ID: 34381374
[No Abstract] [Full Text] [Related]
5. 1,25(OH)
Chen H; Zhu MZ; Wang XT; Ai M; Li SS; Wan MY; Wang PY; Cai WW; Hou B; Xu F; Lang F; Qiu LY; Zhou YT
IUBMB Life; 2024 Apr; 76(4):182-199. PubMed ID: 37921568
[TBL] [Abstract][Full Text] [Related]
6. Potential treatment of squamous cell carcinoma by targeting heparin-binding protein 17/fibroblast growth factor-binding protein 1 with vitamin D
Shintani T; Higaki M; Rosli SNZ; Okamoto T
In Vitro Cell Dev Biol Anim; 2024 May; ():. PubMed ID: 38713345
[TBL] [Abstract][Full Text] [Related]
7. High-dose vitamin D metabolite delivery inhibits breast cancer metastasis.
Liu J; Shen J; Mu C; Liu Y; He D; Luo H; Wu W; Zheng X; Liu Y; Chen S; Pan Q; Hu Y; Ni Y; Wang Y; Liu Y; Li Z
Bioeng Transl Med; 2022 Jan; 7(1):e10263. PubMed ID: 35111955
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vitamin D3 biotransformation by the cell lysate of Actinomyces hyovaginalis CCASU-A11-2.
Abbas AM; Elkhatib WF; Aboulwafa MM; Hassouna NA; Aboshanab KM
AMB Express; 2024 Apr; 14(1):43. PubMed ID: 38658456
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the chemical instability of sphaeropsidin A under physiological conditions - degradation studies and structural elucidation of the major metabolite.
van der Westhuyzen AE; Ingels A; Rosière R; Amighi K; Oberer L; Gustafson KR; Wang D; Evidente A; Maddau L; Masi M; de Villiers A; Green IR; Berger W; Kornienko A; Mathieu V; van Otterlo WAL
Org Biomol Chem; 2020 Oct; 18(40):8147-8160. PubMed ID: 33016969
[TBL] [Abstract][Full Text] [Related]
10. The Synthesis and Biological Evaluation of D-Ring-Modified Vitamin D Analogues.
Kawagoe F; Mototani S; Kittaka A
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827637
[TBL] [Abstract][Full Text] [Related]
11. Geographical Factor Influences the Metabolite Distribution of House Edible Bird's Nests in Malaysia.
Tong SR; Lee TH; Cheong SK; Lim YM
Front Nutr; 2021; 8():658634. PubMed ID: 34262923
[No Abstract] [Full Text] [Related]
12. Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D3-26,23-lactone.
Prosser DE; Kaufmann M; O'Leary B; Byford V; Jones G
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12673-8. PubMed ID: 17646648
[TBL] [Abstract][Full Text] [Related]
13. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
Siu-Caldera ML; Sekimoto H; Peleg S; Nguyen C; Kissmeyer AM; Binderup L; Weiskopf A; Vouros P; Uskoković MR; Reddy GS
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):111-21. PubMed ID: 10659699
[TBL] [Abstract][Full Text] [Related]
14. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the cell differentiating agent 1alpha,25(OH)2-16-ene-23-yne vitamin D3 by leukemic cells.
Satchell DP; Norman AW
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):117-24. PubMed ID: 8645610
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Ring-A-seco analogs of 1α,25-dihydroxy-19-norvitamin D3.
Glebocka A; Sicinski RR; Plum LA; Deluca HF
J Steroid Biochem Mol Biol; 2013 Jul; 136():39-43. PubMed ID: 23064199
[TBL] [Abstract][Full Text] [Related]
18. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
